Submitted: 01 Jun 2018
Accepted: 22 Jun 2018
First published online: 30 Sep 2018
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Int J Basic Sci Med. 2018;3(3):133-139.
doi: 10.15171/ijbsm.2018.24
  Abstract View: 630
  PDF Download: 467

Original article

Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia

Sara Milanizadeh 1 ORCiD, Abbas Aliaghaei 2, Mohammad Reza Bigdeli 1, 3 * ORCiD

1 Department of Animal Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University Tehran, Iran
2 Department of Anatomy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Institute for Cognitive and Brain Sciences (ICBS), Shahid Beheshti University, Tehran, Iran


Introduction: Introducing neurotrophic factors is among several new approaches to enhance neural resistance to ischemic condition. Cancer cells such as 4T1 (an invasive breast carcinoma cell line) are the most potent cells with high viability in transplanted area. The 4T1 cells are derived from spontaneous tumors in BALB/c mouse with their pathogenicity which is limited to this animal. Sertoli cells (SCs) can be a proper candidate for increasing the survival of transplanted cells. The SCs not only suppress the immune system, but also secret many growth factors which increase neural survival. The aim of this study was to evaluate the possible neuroprotective effect of 4T1 transplantation on middle cerebral artery occlusion (MCAO) rat model alone and in combination with SCs co-transplantation.

Methods: Rats were categorized into 5 experimental groups as follows: control, sham, SCs, 4T1, and 4T1+SCs treated groups. For transplanting cells into right striatum, stereotaxic surgery was performed. In addition, ischemic surgery was induced after three days. Twenty-four hours after the reperfusion, neurological severity score (NSS), infarct volume, brain edema, and bloodbrain barrier (BBB) permeability were assessed in different areas of the brain including cortex, striatum, and piriform cortex-amygdala (Pir-Amy).

Results: The SCs, 4T1, and SCs+4T1 cells co-transplantation ameliorated neurological deficits and reduced infarct volume, brain edema, and BBB permeability compared to the control group.

Conclusion: Transplanting 4T1 cancer cell along with SCs as a source of neurotrophic factors enhanced neural survival providing a potential new approach in cell therapy.

Please cite this article as follows: Milanizadeh S, Aliaghaei A, Bigdeli MR. Neuroprotective effect of 4T1 and Sertoli cells co-transplantation in animal model of brain ischemia. Int J Basic Sci Med. 2018;3(3):133- 139. doi:10.15171/ ijbms.2018.24.
First name
Last name
Email address
Security code

Article Viewed: 630

Your browser does not support the canvas element.

PDF Downloaded: 467

Your browser does not support the canvas element.